0.8872
price down icon3.04%   -0.0278
after-market Handel nachbörslich: .87 -0.0172 -1.94%
loading
Schlusskurs vom Vortag:
$0.915
Offen:
$0.93
24-Stunden-Volumen:
362.04K
Relative Volume:
0.27
Marktkapitalisierung:
$74.93M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-0.4984
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
+16.74%
1M Leistung:
+10.17%
6M Leistung:
-56.51%
1J Leistung:
-79.30%
1-Tages-Spanne:
Value
$0.8706
$0.9563
1-Wochen-Bereich:
Value
$0.76
$1.01
52-Wochen-Spanne:
Value
$0.5231
$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
Firmenname
Sutro Biopharma Inc
Name
Telefon
650-392-8412
Name
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
Mitarbeiter
269
Name
Twitter
@SutroBio
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
STRO's Discussions on Twitter

Vergleichen Sie STRO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
STRO
Sutro Biopharma Inc
0.8872 77.28M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-16 Hochstufung Piper Sandler Neutral → Overweight
2025-03-17 Herabstufung H.C. Wainwright Buy → Neutral
2025-03-14 Herabstufung BofA Securities Buy → Underperform
2025-03-14 Herabstufung Citizens JMP Mkt Outperform → Mkt Perform
2025-03-14 Herabstufung Wedbush Outperform → Neutral
2024-05-08 Eingeleitet BofA Securities Buy
2023-11-09 Eingeleitet Deutsche Bank Buy
2023-10-06 Eingeleitet Oppenheimer Outperform
2023-03-21 Herabstufung Wells Fargo Overweight → Equal Weight
2022-08-18 Fortgesetzt Wells Fargo Overweight
2021-06-18 Eingeleitet H.C. Wainwright Buy
2020-12-03 Eingeleitet Stifel Buy
2020-09-02 Eingeleitet Jefferies Buy
2020-07-16 Eingeleitet Wells Fargo Overweight
2020-01-13 Eingeleitet SunTrust Buy
2019-10-07 Eingeleitet BTIG Research Buy
2019-07-18 Eingeleitet Deutsche Bank Buy
2019-04-29 Eingeleitet H.C. Wainwright Buy
2018-10-22 Eingeleitet JMP Securities Mkt Outperform
2018-10-22 Eingeleitet Piper Jaffray Overweight
2018-10-22 Eingeleitet Wedbush Outperform
Alle ansehen

Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten

pulisher
Jul 25, 2025

What analysts say about Sutro Biopharma Inc. stockFree Capital Allocation Plans - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Sutro Biopharma Inc. Stock Analysis and ForecastFree Capital Growth Strategies - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

How Sutro Biopharma Inc. stock reacts to Fed policy changesUnrivaled growth potential - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Why Sutro Biopharma Inc. stock attracts strong analyst attentionFree Elite Traders Group - Newser

Jul 25, 2025
pulisher
Jul 23, 2025

Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely - Yahoo Finance

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Sutro Biopharma Inc. stock priceExplosive capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Sutro Biopharma partners with FDA to develop ADC reference materials By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 22, 2025

Sutro Biopharma partners with FDA to develop ADC reference materials - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

FDA Selects Sutro Biopharma's Revolutionary Platform to Shape Future of Cancer Drug Development - Stock Titan

Jul 22, 2025
pulisher
Jul 20, 2025

Is Sutro Biopharma Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 16, 2025

what makes sutro biopharma inc. stock price move sharplyReal Time Alert Service - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

How Sutro Biopharma Inc. stock performs during market volatilityMoney Making Low Risk Plans - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Sutro Biopharma Inc. stock price move sharplyFree Consultation - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Has $33,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jul 10, 2025
pulisher
Jun 30, 2025

Sutro Biopharma, Inc.(NasdaqGM: STRO) dropped from Russell 2000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 25, 2025

Sutro Biopharma Faces NASDAQ Non-Compliance Notice - TipRanks

Jun 25, 2025
pulisher
Jun 17, 2025

Sutro Biopharma (NASDAQ:STRO) Upgraded to Overweight at Piper Sandler - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade to Overweight by Piper S - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Piper Sandler Upgrades Sutro Biopharma to Overweight From Neutral, $2 Price Target - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

Sutro Biopharma (STRO) Receives Upgrade with Promising Drug Prospects | STRO Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Piper Sandler upgrades Sutro Biopharma stock rating on pipeline progress By Investing.com - Investing.com Canada

Jun 16, 2025
pulisher
Jun 16, 2025

Bank of America Corp DE Sells 22,894 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jun 16, 2025

Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):